Correction: A previous version of this story incorrectly said that Jeffrey Saper led the Wilson Sonsini transaction on his own. Saper was instead co-lead with San Diego-based partner Dan Koeppen.
SAN FRANCISCO — Wilson Sonsini Goodrich & Rosati advised San Diego-based Pfenex Inc. in its initial public offering, as the company listed itself on the New York Stock Exchange July 24. The clinical stage biotechnology company registered 8.3 million shares of common stock at a price of $6 per share, though the shares opened and remained below that price, becoming the latest biotech offering to underperform.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]